\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 1
\BOOKMARK [0][-]{chapter.2}{Long-read Sequencing}{}% 2
\BOOKMARK [1][-]{subsection.2.0.1}{Lab Pipeline}{chapter.2}% 3
\BOOKMARK [0][-]{chapter.3}{Whole Transcriptome}{}% 4
\BOOKMARK [1][-]{section.3.1}{Introduction}{chapter.3}% 5
\BOOKMARK [2][-]{subsection.3.1.1}{Mouse model of AD amyloidopathy: J20}{section.3.1}% 6
\BOOKMARK [2][-]{subsection.3.1.2}{Mouse model of AD tauopathy: rTg4510}{section.3.1}% 7
\BOOKMARK [1][-]{section.3.2}{Methods}{chapter.3}% 8
\BOOKMARK [2][-]{subsection.3.2.1}{RNA Extraction}{section.3.2}% 9
\BOOKMARK [1][-]{section.3.3}{Results}{chapter.3}% 10
\BOOKMARK [2][-]{subsection.3.3.1}{Run performance and sequencing metrics}{section.3.3}% 11
\BOOKMARK [2][-]{subsection.3.3.2}{Transcriptome annotation}{section.3.3}% 12
\BOOKMARK [2][-]{subsection.3.3.3}{Isoform diversity}{section.3.3}% 13
\BOOKMARK [2][-]{subsection.3.3.4}{Iso-Seq vs RNA-Seq}{section.3.3}% 14
\BOOKMARK [2][-]{subsection.3.3.5}{Novel isoforms}{section.3.3}% 15
\BOOKMARK [2][-]{subsection.3.3.6}{Intron Retention and Nonsense mediated decay}{section.3.3}% 16
\BOOKMARK [2][-]{subsection.3.3.7}{Fusion Genes}{section.3.3}% 17
\BOOKMARK [2][-]{subsection.3.3.8}{LncRNA}{section.3.3}% 18
\BOOKMARK [2][-]{subsection.3.3.9}{Novel Genes}{section.3.3}% 19
\BOOKMARK [1][-]{section.3.4}{Discussion}{chapter.3}% 20
\BOOKMARK [0][-]{chapter.4}{Targeted Transcriptome}{}% 21
\BOOKMARK [1][-]{section.4.1}{Introduction}{chapter.4}% 22
\BOOKMARK [1][-]{section.4.2}{Methods}{chapter.4}% 23
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 24
\BOOKMARK [2][-]{subsection.4.3.1}{Run performance and sequencing metrics}{section.4.3}% 25
\BOOKMARK [2][-]{subsection.4.3.2}{Transcriptome annotation}{section.4.3}% 26
\BOOKMARK [0][-]{chapter.5}{Transcriptional differences between WT and TG mice}{}% 27
\BOOKMARK [0][-]{chapter.6}{Conclusion}{}% 28
\BOOKMARK [-1][-]{part.1}{ Appendix}{}% 29
\BOOKMARK [0][-]{chapter.1}{Iso-Seq Targeted and Whole Transcriptome Protocol}{part.1}% 30
\BOOKMARK [1][-]{subsection.1.0.1}{Requirement of Sample quality}{chapter.1}% 31
\BOOKMARK [2][-]{subsection.1.0.2}{General}{subsection.1.0.1}% 32
\BOOKMARK [2][-]{subsection.1.0.3}{First Strand Synthesis}{subsection.1.0.1}% 33
\BOOKMARK [2][-]{subsection.1.0.4}{PCR Cycle Optimisation}{subsection.1.0.1}% 34
\BOOKMARK [2][-]{subsection.1.0.5}{Large-Scale PCR}{subsection.1.0.1}% 35
\BOOKMARK [2][-]{subsection.1.0.6}{Bead Purification of Large-Scale PCR Products}{subsection.1.0.1}% 36
\BOOKMARK [2][-]{subsection.1.0.7}{Pooling Fraction 1 \(1X\) and 2 \(0.40X\)}{subsection.1.0.1}% 37
\BOOKMARK [2][-]{subsection.1.0.8}{Target Capture using IDT probes}{subsection.1.0.1}% 38
\BOOKMARK [2][-]{subsection.1.0.9}{SMRTbell Template Preparation}{subsection.1.0.1}% 39
\BOOKMARK [0][-]{chapter.2}{Oxford Nanopore Transcriptome Protocol}{part.1}% 40
